About the Product

Description


Setgas 5 Suppository containing Bisacodyl is used for the treatment of constipation. It helps in stimulating bowel movements and providing quick and effective relief from irregular bowel habits.

Bisacodyl works by stimulating the intestinal muscles and increasing peristalsis, which helps in promoting bowel evacuation. This ensures fast and reliable relief in patients.

The suppository form is especially useful in cases where oral laxatives are not suitable, leading to consistent demand in both hospital and home care settings.

With increasing prevalence of constipation due to lifestyle changes, this product offers strong business potential for retailers and distributors. Its quick action, regular usage, and steady market demand make it a fast-moving product that can drive consistent sales and growth in the gastro segment.

Some patients may experience mild abdominal cramps, rectal irritation, or a burning sensation after use. Rarely, excessive use may lead to dehydration or electrolyte imbalance.

Setgas 5 Suppository is indicated for the treatment of constipation and for bowel evacuation prior to medical procedures or surgery. It helps stimulate bowel movement, relieve discomfort associated with constipation, and ensure effective clearance of the bowel.

This medicine should be used as directed by a healthcare professional. Avoid prolonged or frequent use as it may lead to dependency. Maintain adequate hydration and a fiber-rich diet to support bowel health.

Store in a cool, dry place below 25°C, away from heat. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Setgas 5 Suppository in the PCD pharma franchise market?

Setgas 5 Suppository, containing Bisacodyl 5mg, has strong demand in the gastrointestinal and constipation relief segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners focusing on digestive care portfolios.

Why should medical distributors include Setgas 5 Suppository in their product range?

Medical distributors and agencies can benefit from the consistent demand for laxative suppositories used in acute constipation, bowel evacuation before procedures, and patients unable to take oral laxatives. Setgas 5 Suppository helps strengthen a comprehensive gastroenterology product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Setgas 5 Suppository?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Setgas 5 Suppository with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Setgas 5 Suppository distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted gastrointestinal and constipation relief product range when partnering for Setgas 5 Suppository distribution.

How can I become a distributor or franchise partner for Setgas 5 Suppository?

Medical distributors, stockists, and wholesalers interested in Setgas 5 Suppository can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.